Alzheimer's disease & dementia

LSL60101 compound reduces neuroinflammation and improves cognition

The LSL60101 compound, a specific ligand of the I2-IR receptors in the brain, could shed light on the development of future strategies against Alzheimer's disease. This is stated in the recent studies by the Research Group ...

Oncology & Cancer

Novel class of drugs may help treat deadly lymphoma

A new class of drugs that inhibits a 'master switch' involved in the vast majority of cases of mantle cell lymphoma (MCL), a fatal subtype of non-Hodgkin's lymphoma, has been discovered by researchers at Mount Sinai.

Medical research

New killing mechanism discovered in 'game-changing' antibiotic

Scientists at the University of Liverpool and University of Utrecht have taken another step forward on their quest to develop a viable drug based on teixobactin—a new class of potent natural antibiotic capable of killing ...

Medical research

Saccharin derivatives give cancer cells a not-so-sweet surprise

Saccharin received a bad rap after studies in the 1970s linked consumption of large amounts of the artificial sweetener to bladder cancer in laboratory rats. Later, research revealed that these findings were not relevant ...

page 3 from 7